Current perspectives of sudden cardiac death management in hypertrophic cardiomyopathy.
Lutong PuJialin LiWeitang QiJinquan ZhangHongyu ChenZihuan TangYuchi HanJie WangYucheng ChenPublished in: Heart failure reviews (2023)
Hypertrophic cardiomyopathy (HCM) is an autosomal dominant disorder characterized by left ventricular hypertrophy. Sudden cardiac death (SCD) is a rare but the most catastrophic complication in patients with HCM. Implantable cardioverter-defibrillators (ICDs) are widely recognized as effective preventive measures for SCD. Individualized risk stratification and early intervention in HCM can significantly improve patient prognosis. In this study, we review the latest findings regarding pathogenesis, risk stratification, and prevention of SCD in HCM patients, highlighting the clinic practice of cardiovascular magnetic resonance imaging for SCD management.
Keyphrases
- hypertrophic cardiomyopathy
- left ventricular
- magnetic resonance imaging
- cardiac resynchronization therapy
- end stage renal disease
- primary care
- randomized controlled trial
- chronic kidney disease
- ejection fraction
- heart failure
- healthcare
- mitral valve
- left atrial
- computed tomography
- peritoneal dialysis
- prognostic factors
- aortic stenosis
- patient reported outcomes
- acute coronary syndrome
- coronary artery disease
- diffusion weighted imaging